Bausch + Lomb Announces Second R&D “Teach-in” Webinar

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Event will feature detailed overviews of two innovative contact lens technologies with potential to redefine the standard of care

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the second event in its R&D “Teach-in” webinar series that provides deeper insights on the company’s robust and differentiated product pipeline.

On Monday, June 1, 2026, at 1:00 p.m. ET, Executive Vice President of Research & Development and Chief Medical Officer Yehia Hashad, MD, will be joined by members of his leadership team to discuss two promising contact lens assets currently under development:

  • First-of-its-kind bioactive contact lens would be the first new contact lens material in over 25 years – designed with polymerized hyaluronic acid to provide all-day comfort, hydration and lubrication
  • Cutting-edge silicone hydrogel daily contact lens featuring premium material and advanced design to help slow the progression of myopia

Chairman and CEO Brent Saunders and Executive Vice President and Chief Financial Officer Sam Eldessouky will also participate.

Registration for the live webinar hosted by Citi as part of its Head, Shoulders, Knees, and Toes series can be accessed here. Following the event, a replay will be available on the Investor Relations page of the Bausch + Lomb website.

About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

© 2026 Bausch + Lomb.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  272.68
+1.51 (0.56%)
AAPL  293.32
+5.88 (2.05%)
AMD  455.19
+46.73 (11.44%)
BAC  51.31
-1.44 (-2.73%)
GOOG  397.05
+1.75 (0.44%)
META  609.63
-7.18 (-1.16%)
MSFT  415.12
-5.65 (-1.34%)
NVDA  215.20
+3.70 (1.75%)
ORCL  195.95
+1.36 (0.70%)
TSLA  428.35
+16.56 (4.02%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.